Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components - Breakdown of the Company Revenue (Details)

v3.23.3
Balance Sheet Components - Breakdown of the Company Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Concentration Risk [Line Items]        
Revenues $ 83,967 $ 105,389 $ 239,764 $ 289,150
U.S. revenue        
Concentration Risk [Line Items]        
Revenues 58,354 90,311 171,887 208,690
Non-U.S. revenue        
Concentration Risk [Line Items]        
Revenues $ 25,613 $ 15,078 $ 67,877 $ 80,460